Novo Nordisk invests $60 mln to expand insulin plant in Kalundborg
Tuesday, July 05, 2016
Danish pharmaceutical company Novo Nordisk is investing 400 million Danish crowns ($59.70 million) in a 500 square meter extension of the world's largest insulin production plant in Kalundborg, it said on Monday.
Groundbreaking for the plant extension will take place Monday and the extension is expected to is expected to be completed at the end of 2018, the company said.
Source : reuters.com
